Bulletin
Investor Alert

New York Markets Open in:

Health Catalyst Inc.

NAS: HCAT

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 22, 2020, 5:24 p.m.

/zigman2/quotes/213268802/composite

$

34.50

Change

+0.15 +0.44%

Volume

Volume 3,715

Quotes are delayed by 20 min

/zigman2/quotes/213268802/composite

Previous close

$ 34.34

$ 34.35

Change

+0.01 +0.03%

Day low

Day high

$33.31

$34.45

Open

52 week low

52 week high

$17.48

$41.26

Open

Company Description

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Profe...

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in Salt Lake City, UT.

Valuation

Price to Sales Ratio

4.20

Price to Book Ratio

6.34

Enterprise Value to Sales

3.06

Total Debt to Enterprise Value

0.11

Efficiency

Revenue/Employee

172,157.00

Income Per Employee

-66,773.00

Receivables Turnover

5.61

Total Asset Turnover

0.75

Liquidity

Current Ratio

5.46

Quick Ratio

5.46

Cash Ratio

4.73

Profitability

Gross Margin

45.50

Operating Margin

-35.12

Pretax Margin

-38.69

Net Margin

-38.79

Return on Assets

-29.08

Return on Equity

-50.99

Return on Total Capital

-34.52

Return on Invested Capital

-38.95

Capital Structure

Total Debt to Total Equity

26.25

Total Debt to Total Capital

20.79

Total Debt to Total Assets

17.42

Long-Term Debt to Equity

24.85

Long-Term Debt to Total Capital

19.68

Officers and Executives

Name Age Officer Since Title
Mr. Daniel D. Burton 44 2011 President
Mr. Paul Horstmeier 58 2011 Senior Vice President
Mr. Patrick J. Nelli 32 2013 Chief Financial Officer
Mr. Dale Sanders 59 2011 Chief Technology Officer
Ms. Holly Rimmasch - - Chief Clinical Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/15/2020 Daniel H. Orenstein
General Counsel
600   Disposition at $36.3 per share. 21,780
09/15/2020 Daniel H. Orenstein
General Counsel
4,400   Disposition at $35.61 per share. 156,684
09/15/2020 Daniel H. Orenstein
General Counsel
5,000   Derivative/Non-derivative trans. at $10.34 per share. 51,700
09/14/2020 Timothy Gregg Ferris
Director
339   Disposition at $35.99 per share. 12,200
09/14/2020 Timothy Gregg Ferris
Director
1,994   Disposition at $35.39 per share. 70,567
09/14/2020 Timothy Gregg Ferris
Director
2,333   Derivative/Non-derivative trans. at $11.78 per share. 27,482
09/10/2020 Anita V. Pramoda
Director
34,000   Disposition at $34.18 per share. 1,162,120
09/01/2020 Dale Sanders
Chief Technology Officer
13,410   Disposition at $32.06 per share. 429,924
09/01/2020 Dale Sanders
Chief Technology Officer
14,090   Disposition at $31.29 per share. 440,876
09/01/2020 Paul Horstmeier
Chief Operating Officer
5,472   Disposition at $32.04 per share. 175,322
09/01/2020 Paul Horstmeier
Chief Operating Officer
5,278   Disposition at $31.25 per share. 164,937
09/01/2020 Linda Llewelyn
Chief People Officer
803   Disposition at $31.38 per share. 25,198
09/01/2020 Linda Llewelyn
Chief People Officer
318   Disposition at $32.09 per share. 10,204
09/01/2020 Linda Llewelyn
Chief People Officer
1,121   Disposition at $31.11 per share. 34,874
09/01/2020 Dale Sanders
Chief Technology Officer
27,500   Derivative/Non-derivative trans. at $10.8 per share. 297,000
09/01/2020 Paul Horstmeier
Chief Operating Officer
10,750   Derivative/Non-derivative trans. at $15.84 per share. 170,280
09/01/2020 Linda Llewelyn
Chief People Officer
1,121   Derivative/Non-derivative trans. at $10.8 per share. 12,106
09/01/2020 Linda Llewelyn
Chief People Officer
1,121   Derivative/Non-derivative trans. at $10.8 per share. 12,106
08/25/2020 Daniel D. Burton
Chief Executive Officer; Director
10,933   Disposition at $30.88 per share. 337,611
08/25/2020 Daniel D. Burton
Chief Executive Officer; Director
6,080   Disposition at $30.34 per share. 184,467
08/25/2020 Daniel D. Burton
Chief Executive Officer; Director
17,013   Derivative/Non-derivative trans. at $15.84 per share. 269,485
08/24/2020 Daniel D. Burton
Chief Executive Officer; Director
93,838   Disposition at $30.24 per share. 2,837,661
08/24/2020 Daniel D. Burton
Chief Executive Officer; Director
8,301   Disposition at $31.18 per share. 258,825
08/24/2020 Daniel D. Burton
Chief Executive Officer; Director
1,900   Disposition at $32 per share. 60,800
08/24/2020 Daniel D. Burton
Chief Executive Officer; Director
20   Derivative/Non-derivative trans. at $6.24 per share. 124
08/24/2020 Daniel D. Burton
Chief Executive Officer; Director
5,465   Derivative/Non-derivative trans. at $10.8 per share. 59,022
08/24/2020 Daniel D. Burton
Chief Executive Officer; Director
98,554   Derivative/Non-derivative trans. at $15.84 per share. 1,561,095
08/21/2020 Daniel D. Burton
Chief Executive Officer; Director
2,571   Disposition at $32.68 per share. 84,020
08/21/2020 Daniel D. Burton
Chief Executive Officer; Director
69,694   Disposition at $32.08 per share. 2,235,783
08/21/2020 Daniel D. Burton
Chief Executive Officer; Director
72,265   Derivative/Non-derivative trans. at $10.8 per share. 780,462
08/20/2020 Daniel D. Burton
Chief Executive Officer; Director
50,603   Disposition at $32.4 per share. 1,639,537
08/20/2020 Daniel D. Burton
Chief Executive Officer; Director
50,603   Derivative/Non-derivative trans. at $10.8 per share. 546,512
08/19/2020 Daniel D. Burton
Chief Executive Officer; Director
64,545   Disposition at $32.44 per share. 2,093,839
08/19/2020 Daniel D. Burton
Chief Executive Officer; Director
64,545   Derivative/Non-derivative trans. at $10.8 per share. 697,086
08/18/2020 Daniel D. Burton
Chief Executive Officer; Director
85,142   Disposition at $32.58 per share. 2,773,926
08/18/2020 Daniel D. Burton
Chief Executive Officer; Director
85,142   Derivative/Non-derivative trans. at $10.8 per share. 919,533
/news/latest/company/us/hcat

MarketWatch News on HCAT

  1. Health Catalyst stock price target raised to $40 from $32 at SVB Leerink

    6:02 a.m. July 10, 2020

    - Tomi Kilgore

  2. Health Catalyst started at buy with $40 stock price target at Canacord Genuity

    12:09 p.m. April 2, 2020

    - Tomi Kilgore

  3. Health Catalyst price target decreased to $35 from $46 at SunTrust

    7:26 a.m. March 26, 2020

    - Emily Bary

  4. Health Catalyst started at buy with $53 stock price target at SunTrust RH

    7:49 a.m. Aug. 19, 2019

    - Tomi Kilgore

  5. Health Catalyst started at overweight with $50 stock price target at J.P. Morgan

    7:40 a.m. Aug. 19, 2019

    - Tomi Kilgore

  6. Livongo, Health Catalyst price IPOs

    9:48 a.m. July 25, 2019

    - Sarah Toy

  7. Health Catalyst upsizes planned IPO, raises price range

    8:50 a.m. July 23, 2019

    - Ciara Linnane

  8. Health Catalyst sets IPO terms, to raise up to $138 mln

    6:32 a.m. July 12, 2019

    - Tomi Kilgore

/news/nonmarketwatch/company/us/hcat

Other News on HCAT

  1. Tracking Chase Coleman's Tiger Global Portfolio - Q2 2020 Update

    1:29 p.m. Sept. 10, 2020

    - Seeking Alpha

  2. Health Catalyst - Looks Cheap But Where Is The Catalyst?

    3:45 a.m. Aug. 30, 2020

    - Seeking Alpha

  3. Schrodinger (SDGR) Catches Eye: Stock Jumps 9.3%

    9:57 a.m. Aug. 14, 2020

    - Zacks.com

  4. 1Life Healthcare (ONEM) Soars: Stock Adds 9% in Session

    8:50 a.m. Aug. 14, 2020

    - Zacks.com

  5. Health Catalyst Q2 2020 Earnings Preview

    5:35 p.m. Aug. 10, 2020

    - Seeking Alpha

  6. iRhythm (IRTC) Looks Good: Stock Adds 9.6% in Session

    9:29 a.m. Aug. 10, 2020

    - Zacks.com

  7. 3 Medical Product Stocks Set to Beat This Earnings Season

    11:17 a.m. Aug. 4, 2020

    - Zacks.com

  8. Health Catalyst's Shares March Higher, Can It Continue?

    10:11 a.m. July 23, 2020

    - Zacks.com

  9. Health Catalyst to acquire healthfinch in cash and stock deal

    4:54 p.m. July 9, 2020

    - Seeking Alpha

  10. 10-Q: HEALTH CATALYST, INC.

    6:03 a.m. May 13, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  11. Livongo Health In Remote Healthcare Delivery Driver's Seat

    5:44 p.m. May 12, 2020

    - Seeking Alpha

  12. Loading more headlines...

At a Glance

Health Catalyst, Inc.

3165 Millrock Drive

Suite 400

Salt Lake City, Utah 84121

Phone

1 8553096800

Industry

Software

Sector

Technology

Fiscal Year-end

12/2020

Revenue

$154.94M

Net Income

$-60.10M

2019 Sales Growth

37.6%

Employees

900.00

/news/pressrelease/company/us/hcat

Press Releases on HCAT

  1. Global Pain Management Devices Market Could Exceed $9 Billion By 2026

    8:34 a.m. Sept. 15, 2020

    - Financial News Media

  2. Global Pain Management Devices Market Could Exceed $9 Billion By 2026

    8:30 a.m. Sept. 15, 2020

    - PR Newswire - PRF

  3. Health Catalyst to Participate in Upcoming Investor Conference

    8:30 a.m. Sept. 9, 2020

    - GlobeNewswire

  4. Health Catalyst Reports Second Quarter 2020 Results

    4:45 p.m. Aug. 11, 2020

    - GlobeNewswire

  5. Health Catalyst to Participate in Upcoming Investor Conferences

    4:15 p.m. Aug. 10, 2020

    - GlobeNewswire

  6. Health Catalyst Offers Planning Resources for COVID-19 Recovery

    8:25 a.m. July 28, 2020

    - PR Newswire - PRF

  7. Health Catalyst Launches New Care Management Solution

    8:00 a.m. July 1, 2020

    - PR Newswire - PRF

  8. Health Catalyst Reports First Quarter 2020 Results

    4:36 p.m. May 12, 2020

    - GlobeNewswire

  9. Loading more headlines...
Link to MarketWatch's Slice.